Patent Application Titled "Chimeric Antigen And T Cell Receptors And Methods Of Use" Published Online (USPTO 20240115611).

The US Patent and Trademark Office has published a patent application titled "Chimeric Antigen And T Cell Receptors And Methods Of Use." The inventors propose an antigen binding system that enhances the ability of T cells to target and kill cancer cells. The invention involves engineering T cells to express constructs that direct them to specific tumor antigens. The patent application provides a method for treating cancer or inducing an immune response by administering a cell expressing a receptor with binding specificity to CD20. The full patent application, including additional claims, can be accessed using the provided URL. [Extracted from the article]

Copyright of Blood Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)